European Pharmaceutical Review

APRIL 14, 2023

According to the authors, self-amplifying RNA (saRNA) could be a next-generation vaccine platform, but it requires smart drug delivery vehicles to maintain the long-term stability and efficiency of the drug. The current NA dosage forms and novel DDSs have enabled the successful launch of NA therapeutics globally. Ingle et al.

Dosage 105

Dosage Vaccines 105

PharmaShots

FEBRUARY 21, 2023

Market Cap: $8.46M Founded Year: 2004 Total Employees: ~4 Headquarters: Texas, United States Stock Exchange: OTCMKTS QSam Biosciences is a clinical-stage biotech company focused on developing and commercializing targeted therapeutic radiopharmaceutical products for treating cancer and related diseases.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

ISPE

SEPTEMBER 11, 2023

POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy. September 2004. Duplication enables rapid scale-up and scale-out, new facilities can be constructed in less than 12 months, and isolated operation avoids cross-contamination. Journal of Pharmaceutical Sciences 111, no.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

AUGUST 30, 2022

During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. 6 US Food and Drug Administration. Burke, S., Hammond, and T.

Documentation 52

Documentation FDA Packaging Communication 52